Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways

Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways

The authors have retracted this article [1] because Figure 4a has been duplicated from Figure 5d in a previously published article [2]. In addition, the article contains sections that substantially overlap with the following articles (amongst others) [3–5]. The data reported in this article are ther...

Full description

Bibliographic Details
Main Authors: Jun Wan, Jie Cui, Lei Wang, Kunpeng Wu, Xiaoping Hong, Yulin Zou, Shuang Zhao, Hong Ke
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cancer Cell International
Online Access:http://link.springer.com/article/10.1186/s12935-019-1019-3
id doaj-a773c00e44c2499fbb29aeb5d04ab2a4
record_format Article
spelling doaj-a773c00e44c2499fbb29aeb5d04ab2a42020-11-25T04:08:41ZengBMCCancer Cell International1475-28672019-11-011911110.1186/s12935-019-1019-3Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathwaysJun Wan0Jie Cui1Lei Wang2Kunpeng Wu3Xiaoping Hong4Yulin Zou5Shuang Zhao6Hong Ke7Department of Pharmacy, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalDepartment of Pharmacy, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalDepartment of Pathogenic Biology, School of Medicine, China Three Gorges UniversityDepartment of Pharmacy, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalDepartment of Pharmacy, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalDepartment of Pharmacy, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalDepartment of Pharmacy, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalDepartment of Oncology, Third Clinical Medical College, Three Gorges University, Gezhouba Group Central HospitalThe authors have retracted this article [1] because Figure 4a has been duplicated from Figure 5d in a previously published article [2]. In addition, the article contains sections that substantially overlap with the following articles (amongst others) [3–5]. The data reported in this article are therefore unreliable. Author Hong Ke stated on behalf of all co-authors that they agree to this retraction.http://link.springer.com/article/10.1186/s12935-019-1019-3
collection DOAJ
language English
format Article
sources DOAJ
author Jun Wan
Jie Cui
Lei Wang
Kunpeng Wu
Xiaoping Hong
Yulin Zou
Shuang Zhao
Hong Ke
spellingShingle Jun Wan
Jie Cui
Lei Wang
Kunpeng Wu
Xiaoping Hong
Yulin Zou
Shuang Zhao
Hong Ke
Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
Cancer Cell International
author_facet Jun Wan
Jie Cui
Lei Wang
Kunpeng Wu
Xiaoping Hong
Yulin Zou
Shuang Zhao
Hong Ke
author_sort Jun Wan
title Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
title_short Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
title_full Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
title_fullStr Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
title_full_unstemmed Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
title_sort retraction note to: excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer panc‑1 cell apoptosis via activating the mros‑htra2/omi pathways
publisher BMC
series Cancer Cell International
issn 1475-2867
publishDate 2019-11-01
description The authors have retracted this article [1] because Figure 4a has been duplicated from Figure 5d in a previously published article [2]. In addition, the article contains sections that substantially overlap with the following articles (amongst others) [3–5]. The data reported in this article are therefore unreliable. Author Hong Ke stated on behalf of all co-authors that they agree to this retraction.
url http://link.springer.com/article/10.1186/s12935-019-1019-3
work_keys_str_mv AT junwan retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT jiecui retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT leiwang retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT kunpengwu retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT xiaopinghong retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT yulinzou retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT shuangzhao retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
AT hongke retractionnotetoexcessivemitochondrialfragmentationtriggeredbyerlotinibpromotespancreaticcancerpanc1cellapoptosisviaactivatingthemroshtra2omipathways
_version_ 1724424396490145792

Similar Items